EvidentIQ’s Post

Join Scout at #OCTEU Did you know that replacing a patient on a clinical trial can cost around $20,000 on average? Stop by for a chat and discover how Scout's services can enhance patient engagement and help minimize the need for patient replacement. #patientcentric #welovewhatwedo #clinicaltrials

🎯 PERIIA Board Meets with European Commission Representatives to Discuss Future Plans and Strengthening Research & Innovation Ecosystems🎯 In a recent online meeting, PERIIA Board members engaged in a productive dialogue with representatives from the European Commission's DG Research & Innovation, Open Science, and Research Infrastructures. During the meeting, the EC representatives were given an overview of PERIIA's ongoing activities and ambitious future plans. The primary aim of this discussion was to solicit feedback on PERIIA’s work programme for the next two years. The insights and recommendations from the EC are seen as crucial in shaping the programme to better align with the broader goals of European research and innovation. 👉 The meeting underscored the importance of collaboration and the need for strategic alignment between PERIIA's initiatives and the European Commission's vision for research and innovation. PERIIA is committed to integrating the EC’s feedback to refine its strategies, ensuring that its efforts contribute significantly to the enhancement of RIs cooperation and the promotion of sustainable innovation across Europe. 🏹 The PERIIA Board was represented by Belén Del Cerro, Christian Dierick, Paolo Acunzo, Jan Visser, Nikolaj Zangenberg, and Eleonora Getsova. Stay tuned for further updates as PERIIA continues to advance its mission in partnership with key stakeholders from the European research and innovation community. #researchinfrastructures #ILOs

VCTC are at OCT Europe! 🌟 Pop by and talk to Helen Shaw (nee Kirkby), Hugh McEnery and Dan Henley to learn how our patient-centric research site can help deliver your trials faster and more cost-effectively💡 You can find us at Booth 16 - come and say hello! 👋 #octeurope #vctc #empoweringpatients #patientcentricity #decentralisedtrials #virtualtrials #clinicaltrialsite #clinicalresearch

Be sure to follow the UChicago Medicine Center for Digital Transformation and Innovation (CDTI) page now on LinkedIn! This initiative is all about taking a holistic approach to healthcare transformation—not just focusing on technology, but also on design, culture, and making it all work in the real world. If you're interested in staying updated on how we're pushing the boundaries of healthcare innovation at UChicago Medicine, follow the CDTI page here on LinkedIn. Much more on the way!

Boston Scientific wins Farapluse approval in China

If you are lucky enough to have escaped Hurricane Helene's wrath and have made it to SCRS, by all means stop by Advarra's booth at #SCRS2024 and say hello to our team. Learn more about how we can assist with your regulatory review needs as well as innovative clinical trials optimization ideas!

Learn more about how you can share your experience and advance ALS research through the ARC Study. Watch our most recent ALS Town Hall recording, led by Alan Premasiri, Sr. Manager, Clinical Operations at ALS TDI here: https://lnkd.in/eEUcJTJC

🎤 Science 37's Alina Wherry, Director of Clin Ops, will be presenting at SCOPE Europe on Tuesday, Oct 29 @ 4:07 PM. Join us for the session on "Unlocking the Power of Decentralised Clinical Trials (DCT): Navigating Trial Design Considerations in Modern Models." We can't wait! #SCOPEEurope #SCOPEEU #SCOPESummit #clinicalresearch #clinicaltrials #clinicalstudies

ALL THINGS ATMP ✅ Recently, ATMP Sweden hosted 12 speakers over 3 days, in a well-executed online conference; the ATMP World Tour 2024 🌍🌎🌏 It covered a wide range of ATMP-related topics, presented by international experts. The recordings from the event are available until the end of this month and you should go check it out, if any of the points below resonate with you: ⭐ It is important to be an ATMP advocate and make a positive impact ⭐ Regulatory systems should be evidence-based and keep up with the speed of innovation ⭐ Access to visible role models in CGT is needed ⭐ Accelerated regulatory approvals are necessary, especially in the rare disease space ⭐ Commercialization of ATMPs is relevant; and keeping ATMPs non-commercial is also important It is evident that the field of ATMP is complex and requires collaboration between a multitude of disciplines to succeed and bring the beneficial therapeutic effects all the way to the patients. Let's keep up the stamina together🚀 #ATMP #cgct #recommendation #collaboration

Gauss, from the suppliers' pillar of the CRMDC, invites you to participate in the first edition of the Costa Rica MD Summit. 🇨🇷🔬 Come and learn more about the industry. #medicaldevices #medicaldevicescostarica #medicalcomponents #gauss #mdsummit